{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:19:28Z","timestamp":1795054768900,"version":"4.10.2"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.urology.2022.09.026","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:57:10Z","timestamp":1666141030000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia"],"prefix":"10.1016","volume":"171","author":[{"given":"Kevin M.","family":"Wymer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viengneesee","family":"Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan J.","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Cheney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell R.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.09.026_bib0001","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I\u2014initial work-up and medical management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0002","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JU.0000000000002184","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II\u2014Surgical evaluation and treatment","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0003","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4111\/icu.2016.57.6.424","article-title":"Nationwide incidence and treatment pattern of benign prostatic hyperplasia in Korea","volume":"57","author":"Lee","year":"2016","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0004","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.juro.2012.07.049","article-title":"Population based trends in the surgical treatment of benign prostatic hyperplasia","volume":"188","author":"Schroeck","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.urology.2011.11.084","article-title":"National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008)","volume":"79","author":"Malaeb","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.026_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","article-title":"A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update","volume":"67","author":"Cornu","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0007","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.ju.0000152318.79184.6f","article-title":"Economic costs of benign prostatic hyperplasia in the private sector","volume":"173","author":"Saigal","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266824","article-title":"A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia","volume":"17","author":"Chughtai","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2022.09.026_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11934-019-0907-3","article-title":"Cost comparison of benign prostatic hyperplasia treatment options","volume":"20","author":"DeWitt-Foy","year":"2019","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2022.09.026_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CEOR.S148195","article-title":"Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"10","author":"Ulchaker","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.urology.2022.09.026_bib0011","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bju.14520","article-title":"Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis","volume":"122","author":"Erman","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.09.026_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00019053-200624020-00006","article-title":"The long-term cost effectiveness of treatments for benign prostatic hyperplasia","volume":"24","author":"DiSantostefano","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.urology.2022.09.026_bib0013","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11255-013-0476-1","article-title":"Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system","volume":"45","author":"De Nunzio","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2022.09.026_bib0014","first-page":"1","volume":"2016","year":"2012"},{"key":"10.1016\/j.urology.2022.09.026_bib0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2022.09.026_bib0016","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.eururo.2006.04.003","article-title":"Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70g: 24-month follow-up","volume":"50","author":"Naspro","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0017","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0022-5347(05)64475-8","article-title":"Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.:: a randomized prospective trial of 120 patients","volume":"168","author":"Kuntz","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.urology.2006.02.007","article-title":"Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis","volume":"68","author":"Salonia","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.026_bib0019","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1097\/01.ju.0000140501.68841.a1","article-title":"Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia","volume":"172","author":"Montorsi","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.eururo.2007.04.053","article-title":"Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial","volume":"52","author":"Ahyai","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0021","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1464-410X.2011.10359.x","article-title":"Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years","volume":"109","author":"Gilling","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2022.09.026_bib0022","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0023","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.09.026_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12894-021-00831-6","article-title":"Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0026","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.juro.2011.06.065","article-title":"Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup","volume":"186","author":"Elmansy","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0027","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0302-2838(02)00403-7","article-title":"The valuation of the international prostate symptom score (IPSS) for use in economic evaluations","volume":"42","author":"Kok","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.09.026_bib0028","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018-advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2022.09.026_bib0029","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/end.2019.0603","article-title":"Mind the gaps: adoption and underutilization of holmium laser enucleation of the prostate in the United States from 2008 to 2014","volume":"34","author":"Robles","year":"2020","journal-title":"J Endourol"},{"key":"10.1016\/j.urology.2022.09.026_bib0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1197\/j.aem.2005.01.006","article-title":"Emergency medicine residency selection: factors influencing candidate decisions","volume":"12","author":"DeSantis","year":"2005","journal-title":"Acad Emerg Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:55:46Z","timestamp":1758768946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522008810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"alternative-id":["S0090429522008810"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.09.026","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}